Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis

Edward Koifman, Michael J. Lipinski, Ricardo O. Escarcega, Romain Didier, Sarkis Kiramijyan, Rebecca Torguson, Ron Waksman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Background New oral anticoagulants (NOAC) and the Watchman device represent an alternative to warfarin for stroke prophylaxis in atrial fibrillation (AF) patients. However, no studies compare these new treatments. We performed a network meta-analysis to indirectly compare Watchman and NOACs among AF patients. Methods We performed a MEDLINE search for studies comparing warfarin with NOACs (dabigatran, rivaroxaban, apixaban and edoxaban) or Watchman in AF patients with reported clinical outcomes. Mixed treatment comparison model generation was performed to directly and indirectly compare NOACs, warfarin and Watchman. Results 14 studies with 246,005 patients were included in the analysis, among which 124,823 were treated with warfarin, 120,450 were treated with NOACs and 732 had Watchman implanted. Mean age was 72 ± 9 years, 53% were male, and mean CHADS2 score was 2.1 ± 1.6. Both NOACs and Watchman were superior to warfarin in hemorrhagic stroke prevention (OR = 0.46 [0.30-0.82] and OR = 0.21 [0.05-0.99], respectively). NOACs significantly reduced total stroke (OR = 0.78 [0.58-0.96]) and major bleeding (OR = 0.78 [0.65-0.91]) compared with warfarin. Indirect comparison between NOAC and Watchman revealed no significant differences in outcomes, though there was a trend toward higher rates of ischemic stroke with Watchman compared with NOAC (OR 2.60 [0.60-13.96]) with the opposite findings with hemorrhagic stroke (OR = 0.44 [0.09-2.14]). Conclusions NOAC therapy was superior to warfarin for multiple outcomes while Watchman reduced hemorrhagic stroke. Further studies are needed to assess Watchman versus NOAC to optimize therapy for stroke prevention in AF patients.

Original languageEnglish
Pages (from-to)17-22
Number of pages6
JournalInternational Journal of Cardiology
StatePublished - 15 Feb 2016
Externally publishedYes


  • Atrial fibrillation
  • NOAC
  • Stroke prophylaxis
  • Watchman device


Dive into the research topics of 'Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis'. Together they form a unique fingerprint.

Cite this